New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
SELLAS Life Sciences Group, Inc.
SLS
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

101M

Biotechnology

Next Earning date - 27 Mar 2025

101M

Biotechnology

Next Earning date - 27 Mar 2025

1.28USD

Shape-0.09 ( -6.57%)
Market Closed (as of Feb 10, 21:00 EDT)
favorite-chart

Relative Strenght

89
favorite-chart

Volume Buzz

8%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

30%

Quote Panel

Shape
Updated February 11, 2025
1W -14.67 % 1M 39.13 % 3M -5.19 % 1Y 62.03 %

Key Metrics

Shape
  • Market Cap

    100.59M


  • Shares Outstanding

    78.58M


  • Share in Float

    76.76M


  • Dividende

    0


  • Earning Date

    27 Mar 2025


  • Price Target

    1.28


  • Average Volume

    2.75M


  • Beta

    2.396


  • Range

    0.66-1.84


  • Industry

    Biotechnology


  • Website

    https://www.sellaslifesciences.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

SLS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$32M

ShapeNaN%

2025-Revenue

$0.45

Shape-353%

2025-EPS

$6M

Shape13%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.43
vs -0.42

Q1.23

arrow
arrow

N/A

-0.47
vs -1.05

Q2.23

arrow
arrow

N/A

-0.31
vs -0.41

Q3.23

arrow
arrow

N/A

-0.33
vs -0.34

Q4.23

arrow
arrow

N/A

-0.25
vs -0.43

Q1.24

arrow
arrow

N/A

-0.21
vs -0.47

Q2.24

arrow
arrow

N/A

-0.13
vs -0.31

Q3.24

arrow
arrow

N/A

-0.10
vs -0.33

Q4.24

arrow
arrow

N/A

-0.11
vs -0.25

Q1.25

arrow
arrow

N/A

-0.10
vs -0.21

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-100%

NA  vs 1.9M

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

+87%

-1000000.00  vs -7600000

Q1.23

arrow
arrow

-100%

NA  vs 1M

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

+100%

NA  vs -1000000

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-177%

-1.77
vs -0.54

Q1.23

arrow
arrow

-83%

-0.83
vs -1.77

Q2.23

arrow
arrow

-183%

-1.83
vs -0.83

Q3.23

arrow
arrow

+242%

2.42
vs -1.83

Q4.23

arrow
arrow

+102%

1.02
vs 2.42

Q1.24

arrow
arrow

-99%

-0.99
vs 1.02

Q2.24

arrow
arrow

-256%

-2.56
vs -0.99

Q3.24

arrow
arrow

-45%

-0.45
vs -2.56

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

31

31
vs 31

NA

Q1.23

arrow
arrow

27

27
vs 31

-13%

Q2.23

arrow
arrow

26

26
vs 27

-4%

Q3.23

arrow
arrow

29

29
vs 26

12%

Q4.23

arrow
arrow

33

33
vs 29

14%

Q1.24

arrow
arrow

33

33
vs 33

NA

Q2.24

arrow
arrow

35

35
vs 33

6%

Q3.24

arrow
arrow

35

35
vs 35

NA

Earnings Growth

Latest News